EquityZen Growth Technology Fund LLC - Series 1442
Raised
$175K
Investors
5
Min Invest
$20,031
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1442 is a Delaware-based pooled investment fund filed by EquityZen Advisors LLC on 2022-09-28, raising $175K from 5 investors under Rule 506(b) and Section 3(c)(1) exemptions with a $20K minimum investment. This is one of nearly 1,900 related entities on the EquityZen platform, which provides access to pre-IPO company shares through individual series vehicles.
This pre-IPO fund follows the standard EquityZen structure: a Rule 506(b) / 3(c)(1) exempt pooled vehicle with a $20K minimum investment, targeting accredited investors seeking exposure to private growth-stage technology companies. The raise size and investor count are consistent with a single-company SPV model typical of secondary marketplace platforms.
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
